UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Global community faces unprecedented opportunity to eliminate hepatitis C’
Hepatitis C accounts for 48 percent of deaths by the liver disease worldwid...
by Lee Han-soo
|
2020-02-18 18:08
라인
Eisai to pull out antiobesity drug Belviq from US market
Eisai Pharmaceutical, a Japan-based multinational drug firm, has decided to...
by Lee Han-soo
|
2020-02-14 16:38
라인
Genematrix’s gastrointestinal infection diagnosis kit wins European certification
Genematrix said that it has received the Conformite Europeenne (CE) Mark fo...
by Lee Han-soo
|
2020-02-14 14:37
라인
Daewoong’s sales reached ₩1 trillion milestone in 2019
Daewoong Pharmaceutical said that its sales exceeded 1 trillion won ($845.8...
by Lee Han-soo
|
2020-02-14 14:33
라인
N. Korea’s allegation on no coronavirus patients raises doubt
The North Korean government has reported no outbreak of the new coronavirus...
by Lee Han-soo
|
2020-02-13 15:48
라인
HIV combo drug worked to treat 3rd patient
A medical team at Myongji Hospital said Wednesday that an HIV combination d...
by Lee Han-soo
|
2020-02-13 15:04
라인
Dong-A ST posts robust profit in 2019
Dong-A ST said Thursday that it recorded sales of 612.2 billion won ($518.2...
by Lee Han-soo
|
2020-02-13 14:20
라인
Myongji Hospital discharges 2 coronavirus patients
Myongji Hospital discharged two patients of new coronavirus on Wednesday, d...
by Lee Han-soo
|
2020-02-12 18:03
라인
Bridge Biotherapeutics, Konkuk University to develop back-eye diseases treatment
Bridge Biotherapeutics has agreed with Konkuk University to introduce techn...
by Lee Han-soo
|
2020-02-12 14:49
라인
GC’s sales rose but profits fell in 2019
GC said Wednesday it recorded sales of 1.36 trillion won ($1.1 billion) las...
by Lee Han-soo
|
2020-02-12 11:40
라인
Medipost’s sales edge up, losses widen last year
Medipost said Wednesday that the company’s operating and net losses magnifi...
by Lee Han-soo
|
2020-02-12 11:40
라인
People under coronavirus test triple as Seoul adds new test centers
The Ministry of Health and Welfare (MOHW) said the new coronavirus testing ...
by Lee Han-soo
|
2020-02-08 17:33
라인
Koreans see coronavirus infection will hurt their health, finance severely
Koreans believe they will unlikely get the new coronavirus, but, if infecte...
by Lee Han-soo
|
2020-02-07 18:41
라인
Nation confirms 24th new coronavirus patient
The Korea Centers for Disease Control and Prevention (KCDC) said on Friday ...
by Lee Han-soo
|
2020-02-07 16:40
라인
Myongji Hospital goes all out to recover 2 coronavirus patients
Korea has confirmed 24 new coronavirus patients as of Friday. The public at...
by Lee Han-soo
|
2020-02-07 15:55
라인
Myongji Hospital training center of sports medicine for foreign doctors
Myongji Hospital's Sports Medicine Center, operated by the hospital’s p...
by Lee Han-soo
|
2020-02-06 16:14
라인
‘Baricitinib emerges as potential treatment for new coronavirus’
Benevolent AI, a U.K.-based artificial intelligence (AI) healthcare firm, h...
by Lee Han-soo
|
2020-02-05 16:32
라인
3 more confirmed cases bring total to 19 in Korea
The Korea Centers for Disease Control and Prevention (KCDC) said Wednesday ...
by Lee Han-soo
|
2020-02-05 12:40
라인
Korea to impose tougher penalties against face mask hoarding
The government will pass a law imposing heavier fines on companies that try...
by Lee Han-soo
|
2020-02-04 18:35
라인
IMC researchers release treatment details of 1st new coronavirus patient
A team at Incheon Medical Center (IMC) has published a report on the epidem...
by Lee Han-soo
|
2020-02-04 17:34
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top